All lobbying filings
BRAVO GROUP
BRAVO GROUP filed a Q4 report for PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA on January 20, 2026, reporting $40,000 in lobbying income.
Lobbying for PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA · Advocacy
Filing · LD-2 quarterly report
Q4 report
Reporting period
4th Quarter 2025
Oct 1 - Dec 31 · Posted Jan 20, 2026
Income
$40,000
What the client paid this registrant for the period.
Client based in
District of Columbia
Lobbyists on this filing
1
-
BRANDON FERRANCEPreviously held: Congressional Intern, Staff Assistant, Press Assistant
Government bodies contacted
2
Lobbying activity
1
Biopharmaceutical issues including: social and economic, value of the biopharmaceutical sector, patient access and safety issues, drug importation, life science innovation, and job impact.